Research
My research spans across four areas:
I develop the theories and evidence for how artificial intelligence reshapes healthcare, the supply chains that sustain it, and marketplaces. I view AI not as a plug-in technology but as a system-level intervention that redefines how institutions make decisions, how incentives shape behavior, and how systems respond to disruption.
Trained at Carnegie Mellon in a program spanning business and computer science, I connect algorithms with practice, policy, and institutions. My research develops models of when and how AI is used, showing how deployment choices shape diagnosis, treatment, and trust. I advance these models through randomized trials, economic analyses, and behavioral studies. At the system level, I show how reimbursement, liability, and regulation govern adoption, and how crises expose fragility in pharmaceutical and medical device supply chains. In related work, I study how institutional constraints generate moral hazard in markets, with implications for contracts, multitasking, and service design.
My research unites theory, empirical validation, and institutional analysis to define the emerging discipline of AI in operations. It informs how healthcare, marketplaces, and supply chains can be redesigned to adapt, endure, and evolve, setting the foundations for institutions increasingly defined by the confluence of human and machine intelligence.
Papers by Topic (For a chronological list, visit tinglongdai.com/papers)
Healthcare
‣ Zhang, Minmin, Guihua Wang, and Tinglong Dai. 2026. “ The Spillover Effect of Suspending Non-Essential Surgery: Evidence from Kidney Transplantation .” Management Science, accepted for publication.
‣ Hunt, Matthew S., Tinglong Dai, and Michael D. Abràmoff. 2026. “Evaluating Commercial Multimodal AI for Diabetic Eye Screening and Implications for an Alternative Regulatory Pathway.” npj Digital Medicine, 9: 42. https://www.nature.com/articles/s41746-025-02216-7. [PDF]
‣ Dai, Tinglong, and Shubhranshu Singh. 2025. “Artificial Intelligence on Call: The Physician's Decision of Whether to Use AI in Clinical Practice.” Journal of Marketing Research 62(5): 854–875. https://doi.org/10.1177/00222437251332898.
‣ Dai, Tinglong, Joseph C. Kvedar, and Daniel Polsky. 2025. “Policy Brief: Ambient AI Scribes and the Coding Arms Race.” npj Digital Medicine, Vol. 8, Article No. 780, Dec. 24, 2025. https://www.nature.com/articles/s41746-025-02272-z. [PDF]
‣ Socal, Mariana P., Yunxiang Sun, Jeromie M. Ballreich, Jennifer Dailey Lambert, Tinglong Dai, and Maqbool Dada. 2025. “US Antibiotic Importation and Supply Chain Vulnerabilities.” JAMA Health Forum 6(10): e253871. Published online October 3, 2025. https://doi.org/10.1001/jamahealthforum.2025.3871. [PDF]
‣ Li, Michael Lingzhi, and Tinglong Dai. 2025. “The Future in Sight: LumineticsCore and the First Autonomous AI for Diagnostics.” Harvard Business School Case. Product #: 626019-PDF-ENG.
‣ Lai, Jiayi, Leon Xu, Xin Fang, and Tinglong Dai. 2025. “Regulating Adaptive New Products: Can Less Oversight Lead to Better Development Practices?.” Working paper. https://doi.org/10.2139/ssrn.5009572.
‣ Dai, Tinglong, and Simrita Singh. 2025. “Using Artificial Intelligence as Gatekeeper or Second Opinion: Designing Patient Pathways for Artificial Intelligence Augmented Healthcare.” Production and Operations Management, forthcoming. https://doi.org/10.1177/10591478251403269.
‣ Dai, Tinglong, and Shubhranshu Singh. 2025. “Overdiagnosis and Undertesting for Infectious Diseases.” Marketing Science 44(2): 353–373. https://doi.org/10.1287/mksc.2022.0038.
◦ Featured by New York Times and VoxEU
◦ Selected by COVID Economics as lead article of Issue 58
‣ Lee, Branden, Patrick Kramer, Sara Sandri, Ritika Chanda, Crystal Favorito, Olivia Nasef, Joseph S. Ross, Joshua Sharfstein, Tinglong Dai. 2025. “Early Recalls and Clinical Validation Gaps in Artificial Intelligence–Enabled Medical Devices.” JAMA Health Forum 6(8): e253172. https://doi.org/10.1001/jamahealthforum.2025.3172. [PDF]
‣ Yang, Haiyang, Tinglong Dai, Nestoras Mathioudakis, Amy M. Knight, Yuna Nakayasu, and Risa M. Wolf . 2025. “Peer Perceptions of Clinicians Using Generative AI in Medical Decision-Making.” npj Digital Medicine 8: 530. https://www.nature.com/articles/s41746-025-01901-x. [PDF]
‣ Lee, Branden, Shivam Patel, Crystal Favorito, Sara Sandri, Maria Rain Jennings, and Tinglong Dai. 2025. “Development and Commercialization Pathways of AI Medical Devices in the United States: Implications for Safety and Regulatory Oversight.” NEJM AI 2(7): AIra2500061. https://ai.nejm.org/doi/10.1056/AIra2500061. [PDF]
‣ Socal, Mariana P., Joy Acha, Chia-Yu Yang, Yunxiang Sun, Maqbool Dada, Tinglong Dai, Gerard Anderson, and Jeromie Ballreich. 2025. “Key Drivers and Mitigation Strategies of Oncology Drug Shortages 2023 to 2025.” The Cancer Journal 31(5). https://doi.org/10.1097/ppo.0000000000000791.
‣ Martagan, Tugce, and Tinglong Dai. 2025. “Synergizing Artificial Intelligence and Operations Research for Advancements in Biomanufacturing.” Health Care Management Science, 28 (4): 930–935. https://doi.org/10.1007/s10729-025-09725-7.
‣ Dai, Tinglong, Risa M. Wolf, and Haiyang Yang. 2025. Unlearning in Medical AI: A New Frontier for Privacy, Regulation, and Trust. Health Affairs Forefront. August 26. http://doi.org/10.1377/forefront.20250822.284476.
‣ Dada, Maqbool, Tinglong Dai, Yunxiang Sun, and Mariana Socal. 2025. “Tariffs as a Hidden Tax: Price Pass-Through in Multi-Stage Supply Chains.” Working paper. http://doi.org/10.2139/ssrn.5237643.
‣ Zhong, Huaiyang, Guihua Wang, and Tinglong Dai. 2025. “Wheels on the Bus: Impact of Vaccine Rollouts on Demand for Public Transportation.” Production and Operations Management, forthcoming. https://doi.org/10.1177/10591478251377162.
‣ Socal, Mariana, Maqbool Dada, and Tinglong Dai. 2025. “Prescription for Made in America? Tariffs and U.S. Drug Manufacturing.” Health Affairs Scholar, forthcoming. https://doi.org/10.1093/haschl/qxaf122. [PDF]
‣ Ahmed, Mahnoor, Tinglong Dai, Roomasa Channa, Michael D. Abramoff, Harold P. Lehmann, and Risa M. Wolf. 2025. “Cost-Effectiveness of AI for Pediatric Diabetic Eye Exams from a Health System Perspective.” npj Digital Medicine 8: 3. https://www.nature.com/articles/s41746-024-01382-4. [PDF]
‣ Sagona, Madeline, Tinglong Dai, Mario Macis, and Michael Darden. 2025. “Trust in AI-Assisted Health Systems and AI’s Trust in Humans.” npj Health Systems 2:10. https://www.nature.com/articles/s44401-025-00016-5.[PDF]
‣ Adida, Elodie, and Tinglong Dai. 2024. “Impact of Physician Payment Scheme on Diagnostic Effort and Testing.” Management Science 70(8): 5408–5425. https://doi.org/10.1287/mnsc.2023.4937.
‣ Abramoff, Michael, Tinglong Dai, and James Zou. 2024. “Scaling Adoption of Medical Artificial Intelligence: Reimbursement from Value-Based Care and Fee-for-Service Perspectives.” NEJM AI 1(5): AIpc2400083. https://ai.nejm.org/doi/10.1056/AIpc2400083. [PDF]
‣ Luan, Shujie, Shubhranshu Singh, and Tinglong Dai. 2024. “Algorithmic Bias and Physician Liability.” Working paper. https://doi.org/10.2139/ssrn.5046254.
‣ Adida, Elodie, and Tinglong Dai. 2025. “Provider Payment Models for Transformative Technologies in Healthcare.” Working paper. http://dx.doi.org/10.2139/ssrn.5097711.
‣ Dai, Tinglong, and Michael D. Abramoff. 2023. “Incorporating Artificial Intelligence into Healthcare Workflows: Models and Insights.” INFORMS TutORials in Operations Research, 133–155. https:/doi.org/10.1287/educ.2023.0257.
‣ Abramoff, Michael D., Noelle Whitestone, Jennifer L. Patnaik, Emily Rich, Munir Ahmed, Lutful Husain, Mohammad Yeadul Hassan, Md. Sajidul Huq Tanjil, Dena Weitzman, Tinglong Dai, Brandie D. Wagner, David H. Cherwek, Nathan Congdon & Khairul Islam. 2023. “Autonomous Artificial Intelligence Increases Real-World Specialist Clinic Productivity in a Cluster-Randomized Trial.” npj Digital Medicine 6: 184. https://www.nature.com/articles/s41746-023-00931-7
‣ Wang, Guihua, Ronghuo Zheng, and Tinglong Dai. 2022. “Does Transportation Mean Transplantation? Impact of New Airline Routes on Sharing of Cadaveric Kidneys.” Management Science 68(5): 3660–3679. https://doi.org/10.1287/mnsc.2021.4103.
◦ Featured in Nobel laureate Al Roth’s Market Design blog
◦ Selected by Financial Times as a runner-up for the 2022 Responsible Business Education Awards
◦ Featured by Associated Press, Austin’ NPR Station—KUT, The Conversation, Financial Times, Public Radio International, National Interest, Simple Flying, and Yahoo! News
‣ Mak, Ho-Yin, Tinglong Dai, and Christopher S. Tang. 2022. “Managing Two-Dose COVID-19 Vaccine Rollouts with Limited Supply: Operations Strategies for Distributing Time-Sensitive Resources.” Production and Operations Management 31 (12): 4424–4442. https://doi.org/10.1111/poms.13862.
‣ Dai, Tinglong, Xiaofang Wang, and Chao-Wei Hwang. 2022. “Clinical Ambiguity and Conflicts of Interest in Interventional Cardiology Decision Making.” Manufacturing & Service Operations Management 24(2): 864–882. https://doi.org/10.1287/msom.2021.0969.
◦ Johns Hopkins Discovery Award, 2015
◦ Production and Operations Management Society (POMS) Best Healthcare Paper Award (Runner-Up), 2016
‣ Dai, Tinglong, and Sridhar Tayur. 2022. “Designing AI-augmented Healthcare Delivery Systems for Physician Buy-in and Patient Acceptance.” Production and Operations Management, 31 (12): 4443–4451. https://doi.org/10.1111/poms.13850.
‣ Ahmadi, Farzin, Tinglong Dai, and Kimia Ghobadi. 2022. “You are What You Eat: A Preference-Aware Inverse Optimization Approach.” Working paper. http://doi.org/10.2139/ssrn.4298746.
‣ Dai, Tinglong, and Jing-Sheng Song. 2021. “Transforming COVID-19 Vaccines into Vaccination.” Health Care Management Science 24 (3): 455–459. https://doi.org/10.1007/s10729-021-09563-3. [lead article]
‣ Jain, Amit, Tinglong Dai, Kristin Bibee, and Christopher G. Myers. 2020. “Covid-19 Created an Elective Surgery Backlog. How Can Hospitals Get Back on Track?” Harvard Business Review, August 10, 2020. https://hbr.org/2020/08/covid-19-created-an-elective-surgery-backlog-how-can-hospitals-get-back-on-track.
‣ Dai, Tinglong, and Sridhar Tayur. 2020. “OM Forum—Healthcare Operations Management: A Snapshot of Emerging Research.” Manufacturing & Service Operations Management 22 (5): 869–887. https://doi.org/10.1287/msom.2019.0778. [lead article]
‣ Balaguru, Logesvar, Chen Dun, Andrea Meyer, Sanuri Hennayake, Christi Walsh, Christopher Kung, Brittany Cary, Frank Migliarese, Tinglong Dai, Ge Bai, Kathleen Sutcliffe, and Martin Makary. 2022. “NIH Funding of COVID-19 Research in 2020: A Cross Sectional Study.” BMJ Open 12(5), e059041. http://dx.doi.org/10.1136/bmjopen-2021-059041
◦ Featured by New York Times
‣ Dai, Tinglong, and Shubhranshu Singh. 2020. “Conspicuous by Its Absence: Diagnostic Expert Testing Under Uncertainty.” Marketing Science 39 (3): 540–563. https://doi.org/10.1287/mksc.2019.1201.
◦ Featured by Agency for Healthcare Research and Quality, Hub of Johns Hopkins University and INFORMS Podcast
‣ Dai, Tinglong, Ronghuo Zheng, and Katia Sycara. 2020. “Jumping the Line, Charitably: Analysis and Remedy of Donor-Priority Rule.” Management Science 66 (2): 622–641. https://doi.org/10.1287/mnsc.2018.3266.
◦ 2017 INFORMS Public Sector Operations Research Best Paper Award (First Place Winner)
‣ Dai, Tinglong, Kelly Gleason, Chao‐Wei Hwang, and Patricia Davidson. 2019. “Heart Analytics: Analytical Modeling of Cardiovascular Care.” Naval Research Logistics 68 (1): 30–43. https://doi.org/10.1002/nav.21880.
‣ Dai, Tinglong, Mustafa Akan, and Sridhar Tayur. 2017. “Imaging Room and Beyond: The Underlying Economics Behind Physicians’ Test-Ordering Behavior in Outpatient Services.” Manufacturing & Service Operations Management 19 (1): 99–113. https://doi.org/10.1287/msom.2016.0594.
◦ 2012 POMS Best Healthcare Paper Award (First Place Winner)
‣ Dai, Tinglong, Soo-Haeng Cho, and Fuqiang Zhang. 2016. “Contracting for On-Time Delivery in the U.S. Influenza Vaccine Supply Chain.” Manufacturing & Service Operations Management 18 (3): 332–346. https://doi.org/10.1287/msom.2015.0574.
◦ Feature Article in the Summer 2016 issue of M&SOM
◦ Featured by Hub of Johns Hopkins University, Washington University in St. Louis Newsroom, and Pharmacy Times
‣ Liljenquist, Dan, Tinglong Dai, and Ge Bai. 2021. “A Nonprofit Public Utility Approach to Enhance Next-Generation Vaccine Manufacturing Capacity.” Population Health Management 24 (5): 546–547. https://doi.org/10.1089/pop.2020.0377.
‣ Lee, Soo-Hoon, Tinglong Dai, Phillip H. Phan, Nehama Moran, and Jerry Stonemetz. 2022. “The Association Between Timing of Elective Surgery Scheduling and Operating Theater Utilization: A Cross-Sectional Retrospective Study.” Anesthesia & Analgesia 134 (3): 455-462. doi:10.1213/ane.0000000000005871.
‣ Jain, Amit, Tinglong Dai, Christopher G Myers, Punya Jain, and Shruti Aggarwal. 2021. “Prioritising Surgical Cases Deferred by the COVID-19 Pandemic: An Ethics-Inspired Algorithmic Framework for Health Leaders.” BMJ Leader 5 (2): 124–126. https://doi.org/10.1136/leader-2020-000343.
‣ Fattahi, Ali, Maqbool Dada, and Tinglong Dai. 2020. “A Subscription Model for Prescription Drugs.” Working paper. https://doi.org/10.2139/ssrn.3634063.
Artificial Intelligence
‣ Cohen, Maxime C., Tinglong Dai, Georgia Perakis, Narendra Agrawal, Gad Allon, Robert Boute, Gérard Cachon, Zhe Chen, Morris Cohen, Rares Cristian, Vinayak Deshpande, Francis de Véricourt, Jan C. Fransoo, Joren Gijsbrechts, Pavithra Harsha, Ming Hu, Pınar Keskinocak, Caleb Kwon, Hau Lee, Sheng Liu, Konstantina Mellou, Ishai Menache, Jason Miller, Serguei Netessine, Tava Olsen, Jeevan Pathuri, Robert Peels, Yongzhi Qi, Ananth Raman, Anne Robinson, Max Shen, Masha Shunko, David Simchi-Levi, Hannah Smalley, Jeannette Song, Jayashankar M. Swaminathan, Christopher S. Tang, Sridhar Tayur, Maxi Udenio, Jan Van Mieghem, Lillian Yuqian Xu, Dennis Zhang. 2025. ”Supply Chain Management in the AI Era: A Vision Statement from the Operations Management Community.” Manufacturing & Service Operations Management, accepted for publication (February 2026). http://dx.doi.org/10.2139/ssrn.5792542.
‣ Hunt, Matthew S., Tinglong Dai, and Michael D. Abràmoff. 2026. “Evaluating Commercial Multimodal AI for Diabetic Eye Screening and Implications for an Alternative Regulatory Pathway.” npj Digital Medicine, 9: 42. https://www.nature.com/articles/s41746-025-02216-7. [PDF]
‣ Dai, Tinglong, and Terry Taylor. 2025. “Designing Enterprise AI Systems: Hallucination, Creativity, and Moral Hazard.” Working paper. https://doi.org/10.2139/ssrn.5996714.
‣ Dai, Tinglong, David Simchi-Levi, Michelle Xiao Wu, and Yao Xie. 2025. “Assured Autonomy: How Operations Research Powers and Orchestrates Generative AI Systems.” Working paper. https://doi.org/10.2139/ssrn.5996875.
‣ Dai, Tinglong, Joseph C. Kvedar, and Daniel Polsky. 2025. “Policy Brief: Ambient AI Scribes and the Coding Arms Race.” npj Digital Medicine, Vol. 8, Article No. 780, Dec. 24, 2025. https://www.nature.com/articles/s41746-025-02272-z. [PDF]
‣ Li, Michael Lingzhi, and Tinglong Dai. 2025. “The Future in Sight: LumineticsCore and the First Autonomous AI for Diagnostics.” Harvard Business School Case. Product #: 626019-PDF-ENG.
‣ Simchi-Levi, David, Tinglong Dai, Ishai Menache, and Michelle Xiao Wu. 2025. “Democratizing Optimization with Generative AI.” Working paper. https://doi.org/10.2139/ssrn.5511218.
‣ Lai, Jiayi, Leon Xu, Xin Fang, and Tinglong Dai. 2025. “Regulating Adaptive New Products: Can Less Oversight Lead to Better Development Practices?.” Working paper. https://doi.org/10.2139/ssrn.5009572.
‣ Dai, Tinglong, and Jayashankar M. Swaminathan. 2025. “Artificial Intelligence and Operations: A Foundational Framework of Emerging Research and Practice.” Production and Operations Management, forthcoming. https://doi.org/10.1177/10591478251412943.
‣ Dai, Tinglong, and Simrita Singh. 2025. “Using Artificial Intelligence as Gatekeeper or Second Opinion: Designing Patient Pathways for Artificial Intelligence Augmented Healthcare .” Production and Operations Management, forthcoming. https://doi.org/10.1177/10591478251403269.
‣ Dai, Tinglong, Risa M. Wolf, and Haiyang Yang. 2025. “Unlearning in Medical AI: A New Frontier for Privacy, Regulation, and Trust.” Health Affairs Forefront. August 26. http://doi.org/10.1377/forefront.20250822.284476.
‣ Lee, Branden, Patrick Kramer, Sara Sandri, Ritika Chanda, Crystal Favorito, Olivia Nasef, Joseph S. Ross, Joshua Sharfstein, Tinglong Dai. 2025. “Early Recalls and Clinical Validation Gaps in Artificial Intelligence–Enabled Medical Devices.” JAMA Health Forum 6(8): e253172. https://doi.org/10.1001/jamahealthforum.2025.3172. [PDF]
‣ Yang, Haiyang, Tinglong Dai, Nestoras Mathioudakis, Amy M. Knight, Yuna Nakayasu, and Risa M. Wolf . 2025. “Peer Perceptions of Clinicians Using Generative AI in Medical Decision-Making.” npj Digital Medicine 8: 530. https://www.nature.com/articles/s41746-025-01901-x. [PDF]
‣ Lee, Branden, Shivam Patel, Crystal Favorito, Sara Sandri, Maria Rain Jennings, and Tinglong Dai. 2025. “Development and Commercialization Pathways of AI Medical Devices in the United States: Implications for Safety and Regulatory Oversight.” NEJM AI 2(7): AIra2500061. https://ai.nejm.org/doi/10.1056/AIra2500061. [PDF]
‣ Dai, Tinglong, and Shubhranshu Singh. 2025. “Artificial Intelligence on Call: The Physician's Decision of Whether to Use AI in Clinical Practice.” Journal of Marketing Research 62(5): 854–875. https://doi.org/10.1177/00222437251332898.
‣ Ahmed, Mahnoor, Tinglong Dai, Roomasa Channa, Michael D. Abramoff, Harold P. Lehmann, and Risa M. Wolf. 2025. “Cost-Effectiveness of AI for Pediatric Diabetic Eye Exams from a Health System Perspective.” npj Digital Medicine 8: 3. https://www.nature.com/articles/s41746-024-01382-4. [PDF]
‣ Martagan, Tugce, and Tinglong Dai. 2025. “Synergizing Artificial Intelligence and Operations Research for Advancements in Biomanufacturing.” Health Care Management Science, 28 (4): 930–935. https://doi.org/10.1007/s10729-025-09725-7.
‣ Wiberg, Holly, Tinglong Dai, Henry Lam, and Radhika Kulkarni. 2025. “Synergizing Artificial Intelligence and Operations Research: Perspectives from INFORMS Fellows on the Next Frontier.” INFORMS Journal on Data Science, ePub ahead of print. https://doi.org/10.1287/ijds.2025.0077.
‣ Sagona, Madeline, Tinglong Dai, Mario Macis, and Michael Darden. 2025. “Trust in AI-Assisted Health Systems and AI’s Trust in Humans.” npj Health Systems 2:10. https://www.nature.com/articles/s44401-025-00016-5.[PDF]
‣ Gilbert, Stephen, Tinglong Dai, and Rebecca Mathias. 2025. “Consternation as Congress Proposal for Autonomous Prescribing AI Coincides With the Haphazard Cuts at the FDA.” npj Digital Medicine 8: 165. https://www.nature.com/articles/s41746-025-01540-2.
‣ Abramoff, Michael, Tinglong Dai, and James Zou. 2024. “Scaling Adoption of Medical Artificial Intelligence: Reimbursement from Value-Based Care and Fee-for-Service Perspectives.” NEJM AI 1(5): AIpc2400083. https://ai.nejm.org/doi/10.1056/AIpc2400083. [PDF]
‣ Luan, Shujie, Shubhranshu Singh, and Tinglong Dai. 2024. “Algorithmic Bias and Physician Liability.” Working paper. https://doi.org/10.2139/ssrn.5046254.
‣ Adida, Elodie, and Tinglong Dai. 2025. “Provider Payment Models for Transformative Technologies in Healthcare.” Working paper. http://dx.doi.org/10.2139/ssrn.5097711.
‣ Ho, Cindy N., Tiffany Tian, Alessandra T. Ayers, Rachel E. Aaron, Vidith Phillips, Risa M. Wolf, Nestoras Mathioudakis, Tinglong Dai, and David C. Klonoff. 2024. “Qualitative Metrics from the Biomedical Literature for Evaluating Large Language Models in Clinical Decision-Making: A Narrative Review.” BMC Medical Informatics and Decision Making 24:357. https://doi.org/10.1186/s12911-024-02757-z.
‣ Dai, Tinglong, and Abramoff, Michael. 2023. “Incorporating Artificial Intelligence into Healthcare Workflows: Models and Insights.” INFORMS TutORials in Operations Research, 133–155. https://doi.org/10.1287/educ.2023.0257.
‣ Dai, Tinglong, and Sridhar Tayur. 2022. “Designing AI-augmented Healthcare Delivery Systems for Physician Buy-in and Patient Acceptance.” Production and Operations Management, 31 (12): 4443–4451. https://doi.org/10.1111/poms.13850.
‣ Abramoff, Michael D., Noelle Whitestone, Jennifer L. Patnaik, Emily Rich, Munir Ahmed, Lutful Husain, Mohammad Yeadul Hassan, Md. Sajidul Huq Tanjil, Dena Weitzman, Tinglong Dai, Brandie D. Wagner, David H. Cherwek, Nathan Congdon, and Khairul Islam. 2023. “Autonomous Artificial Intelligence Increases Real-World Specialist Clinic Productivity in a Cluster-Randomized Trial.” npj Digital Medicine 6: 184. https://www.nature.com/articles/s41746-023-00931-7
‣ Dai, Tinglong, and Shubhranshu Singh. 2020. “Conspicuous by Its Absence: Diagnostic Expert Testing Under Uncertainty.” Marketing Science 39 (3): 540–563. https://doi.org/10.1287/mksc.2019.1201.
◦ Featured by Agency for Healthcare Research and Quality, Hub of Johns Hopkins University and INFORMS Podcast
‣ Adida, Elodie, and Tinglong Dai. 2024. “Impact of Physician Payment Scheme on Diagnostic Effort and Testing.” Management Science 70(8): 5408–5425. https://doi.org/10.1287/mnsc.2023.4937.
‣ Dai, Tinglong, Katia Sycara, and Ronghuo Zheng. 2021. “Agent Reasoning in AI-Powered Negotiation.” Handbook of Group Decision and Negotiation, 2nd Edition. M. Kilgour and C. Eden (Eds). New York: Springer.
‣ Wuest, Thorsten, Andrew Kusiak, Tinglong Dai, and Sridhar R. Tayur. 2020. “Impact of COVID-19 on Manufacturing and Supply Networks — The Case for AI-Inspired Digital Transformation.” Working report. https://doi.org/10.2139/ssrn.3593540.
◦ A shortened version, entitled “Impact of COVID-19: The Case for AI-Inspired Digital Transformation,” was published in the June 2020 issue of OR/MS Today and featured on the cover.
‣ Zheng, Ronghuo, Tinglong Dai, Katia Sycara, and Nilanjan Chakraborty. 2016. “Automated Multilateral Negotiation on Multiple Issues with Private Information.” INFORMS Journal on Computing 28 (4): 612–628. https://doi.org/10.1287/ijoc.2016.0701.
‣ Zheng, Ronghuo, Nilanjan Chakraborty, Tinglong Dai, and Katia Sycara. 2013. “Multiagent Negotiation on Multiple Issues with Incomplete Information.” In Proceedings of the 12th International Conference on Autonomous Agents and Multiagent Systems: AAMAS’13, 1279–1280. https://dl.acm.org/doi/10.5555/2484920.2485182.
‣ Zheng, Ronghuo, Nilanjan Chakraborty, Tinglong Dai, Katia Sycara, and Michael Lewis. 2013. “Automated Bilateral Multiple-Issue Negotiation with No Information About Opponent.” In Proceedings of the 46th Hawaii International Conference on System Sciences. https://doi.org/10.1109/hicss.2013.626.
‣ Xu, Ying, Tinglong Dai, Katia Sycara, and Michael Lewis. 2012. “A Mechanism Design Model to Enhance Performance in Human-Multirobot Teams.” In Proceedings of the Annual Human Agent Robot Teamwork Workshop, Boston, MA.
◦ Cited as the first to propose “the idea of autonomous agents reporting problems to a central authority”
‣ Sanchez-Anguix, Victor, Tinglong Dai, Zhaleh Semnani-Azad, Katia Sycara, and Vicente Botti. 2012. “Modeling Power Distance and Individualism/Collectivism in Negotiation Team Dynamics.” In Proceedings of the 45th Hawaii International Conference on System Sciences. https://doi.org/10.1109/hicss.2012.436.
‣ Xu, Ying, Tinglong Dai, Katia Sycara, and Michael Lewis. 2010. “Service Level Differentiation in Multi-Robots Control.” In Proceedings of 2010 IEEE/RSJ International Conference on Intelligent Robots and Systems. https://doi.org/10.1109/iros.2010.5649366.
Marketing-Operations Interfaces
‣ Dai, Tinglong, and Shubhranshu Singh. 2025. “Artificial Intelligence on Call: The Physician's Decision of Whether to Use AI in Clinical Practice.” Journal of Marketing Research 62(5): 854–875. https://doi.org/10.1177/00222437251332898.
‣ Dai, Tinglong, and Shubhranshu Singh. 2025. “Overdiagnosis and Undertesting for Infectious Diseases.” Marketing Science 44(2): 353–373. https://doi.org/10.1287/mksc.2022.0038.
◦ Featured by New York Times and VoxEU
◦ Selected by COVID Economics as lead article of Issue 58
‣ Dai, Tinglong, Rongzhu Ke, and Christopher Thomas Ryan. 2021. “Incentive Design for Operations-Marketing Multitasking.” Management Science 67 (4): 2211–2230. https://doi.org/10.1287/mnsc.2020.3651.
‣ Zuo, Ruiting, Tinglong Dai, and Jussi Keppo. 2023. “Incentive Design and Pricing under Limited Inventory.” Working paper. http://dx.doi.org/10.2139/ssrn.3989971.
‣ Li, Yifu, Tinglong Dai, and Xiangtong Qi. 2022. A Theory of Interior Peaks: Activity Sequencing and Selection for Service Design. Manufacturing & Service Operations Management 24(2): 993–1001. https://doi.org/10.1287/msom.2021.0970.
◦ 2017 IBM Service Science Best Student Paper Award, Finalist
◦ 2018 POMS-HK International Conference, Best Student Paper Competition, Honorable Mention
‣ Dai, Tinglong, and Shubhranshu Singh. 2020. “Conspicuous by Its Absence: Diagnostic Expert Testing Under Uncertainty.” Marketing Science 39 (3): 540–563. https://doi.org/10.1287/mksc.2019.1201.
◦ Featured by Agency for Healthcare Research and Quality, Hub of Johns Hopkins University and INFORMS Podcast
‣ Yuan, Xuchuan, Tinglong Dai, Lucy Gongtao Chen, and Srinagesh Gavirneni. 2021. “Co-Opetition in Service Clusters with Waiting-Area Entertainment.” Manufacturing & Service Operations Management 23 (1): 106–122. https://doi.org/10.1287/msom.2019.0815.
◦ Featured by INFORMS Press Release and National University of Singapore
‣ Dai, Tinglong, and Kinshuk Jerath. 2019. “Salesforce Contracting Under Uncertain Demand and Supply: Double Moral Hazard and Optimality of Smooth Contracts.” Marketing Science 38 (5): 852–70. https://doi.org/10.1287/mksc.2019.1171.
‣ Chen, Ying-Ju, Tinglong Dai, C. Gizem Korpeoglu, Ersin Körpeoğlu, Ozge Sahin, Christopher S. Tang, and Shihong Xiao. 2020. “OM Forum—Innovative Online Platforms: Research Opportunities.” Manufacturing & Service Operations Management 22 (3): 430–445. https://doi.org/10.1287/msom.2018.0757. [lead article]
‣ Dai, Tinglong, and Kinshuk Jerath. 2016. “Impact of Inventory on Quota-Bonus Contracts with Rent Sharing.” Operations Research 64 (1): 94–98. https://doi.org/10.1287/opre.2015.1461.
‣ Dai, Tinglong, and Kinshuk Jerath. 2013. “Salesforce Compensation with Inventory Considerations.” Management Science 59 (11): 2490–2501. https://doi.org/10.1287/mnsc.2013.1809.
Global Supply Chains
‣ Cohen, Maxime C., Tinglong Dai, Georgia Perakis, Narendra Agrawal, Gad Allon, Robert Boute, Gérard Cachon, Zhe Chen, Morris Cohen, Rares Cristian, Vinayak Deshpande, Francis de Véricourt, Jan C. Fransoo, Joren Gijsbrechts, Pavithra Harsha, Ming Hu, Pınar Keskinocak, Caleb Kwon, Hau Lee, Sheng Liu, Konstantina Mellou, Ishai Menache, Jason Miller, Serguei Netessine, Tava Olsen, Jeevan Pathuri, Robert Peels, Yongzhi Qi, Ananth Raman, Anne Robinson, Max Shen, Masha Shunko, David Simchi-Levi, Hannah Smalley, Jeannette Song, Jayashankar M. Swaminathan, Christopher S. Tang, Sridhar Tayur, Maxi Udenio, Jan Van Mieghem, Lillian Yuqian Xu, Dennis Zhang. 2025. ”Supply Chain Management in the AI Era: A Vision Statement from the Operations Management Community.” Manufacturing & Service Operations Management, accepted for publication (February 2026). http://dx.doi.org/10.2139/ssrn.5792542.
‣ Socal, Mariana P., Yunxiang Sun, Jeromie Ballreich, Joy Acha, Mohammad Ali Yazdi, Tinglong Dai, and Maqbool Dada. 2026. “Potential Impact of Tariffs on Active Pharmaceutical Ingredients on the Price of US-Made Generic Drugs.” Health Affairs Scholar 4(2), qxaf247. https://doi.org/10.1093/haschl/qxaf247. [PDF]
‣ Socal, Mariana P., Yunxiang Sun, Jeromie M. Ballreich, Jennifer Dailey Lambert, Tinglong Dai, and Maqbool Dada. 2025. “US Antibiotic Importation and Supply Chain Vulnerabilities.” JAMA Health Forum 6(10): e253871. Published online October 3, 2025. https://doi.org/10.1001/jamahealthforum.2025.3871. [PDF]
‣ Dai, Tinglong, David Simchi-Levi, Michelle Xiao Wu, and Yao Xie. 2025. “Assured Autonomy: How Operations Research Powers and Orchestrates Generative AI Systems.” Working paper. https://doi.org/10.2139/ssrn.5996875.
‣ Socal, Mariana P., Joy Acha, Chia-Yu Yang, Yunxiang Sun, Maqbool Dada, Tinglong Dai, Gerard Anderson, and Jeromie Ballreich. 2025. “Key Drivers and Mitigation Strategies of Oncology Drug Shortages 2023 to 2025.” The Cancer Journal 31(5). https://doi.org/10.1097/ppo.0000000000000791.
‣ Socal, Mariana, Maqbool Dada, and Tinglong Dai. 2025. “Prescription for Made in America? Tariffs and U.S. Drug Manufacturing.” Health Affairs Scholar, 3(7):qxaf122. https://doi.org/10.1093/haschl/qxaf122. [PDF]
‣ Dai, Tinglong, and Jayashankar M. Swaminathan. 2025. Artificial Intelligence and Operations: A Foundational Framework of Emerging Research and Practice. Production and Operations Management, forthcoming. https://doi.org/10.1177/10591478251412943.
‣ Dada, Maqbool, Tinglong Dai, Yunxiang Sun, and Mariana Socal. 2025. “Tariffs as a Hidden Tax: Price Pass-Through in Multi-Stage Supply Chains.” Working paper. http://doi.org/10.2139/ssrn.5237643.
‣ Dai, Tinglong, and Christopher S. Tang. 2024. “De-risking Global Supply Chains: Looking Beyond Material Flows.” Asia Policy 19 (4): 153–176. https://doi.org/10.1353/asp.2024.a942841. [Free PDF courtesy of the Hinrich Foundation]
‣ Zhong, Huaiyang, Guihua Wang, and Tinglong Dai. 2025. “Wheels on the Bus: Impact of Vaccine Rollouts on Demand for Public Transportation.” Production and Operations Management, forthcoming. https://doi.org/10.1177/10591478251377162.
‣ Dai, Tinglong, and Christopher S. Tang. 2024. “Natural Hazards and Supply Chain.” In Oxford Research Encyclopedia of Natural Hazard Science. D. Benouar (Ed), Oxford University Press. https://doi.org/10.1093/acrefore/9780199389407.013.512.
‣ Dai, Tinglong, Hau L. Lee, and Christopher S. Tang. 2024. “Toward Supply-Chain-Aware ESG Measures.” In Responsible and Sustainable Operations: The New Frontier. C. S. Tang (Ed), pp. 235–252. Springer. https://doi.org/10.1007/978-3-031-60867-4_15.
‣ Dai, Tinglong, and Christopher S. Tang. 2022. “Everybody Talks About Made in America. But It Isn’t That Simple.” Wall Street Journal. October 23. https://on.wsj.com/3zouROt.
‣ Dai, Tinglong, and Christopher S. Tang. 2022. “Integrating ESG Measures and Supply Chain Management: Research Opportunities in the Post-Pandemic Era.” Service Science 14 (1): 1–12. https://doi.org/10.1287/serv.2021.0295. [lead article]
‣ Mak, Ho-Yin, Tinglong Dai, and Christopher S. Tang. 2022. “Managing Two-Dose COVID-19 Vaccine Rollouts with Limited Supply: Operations Strategies for Distributing Time-Sensitive Resources.” Production and Operations Management 31 (12): 4424–4442. https://doi.org/10.1111/poms.13862.
‣ Dai, Tinglong, and Jing-Sheng Song. 2021. “Transforming COVID-19 Vaccines into Vaccination.” Health Care Management Science 24 (3): 455–459. https://doi.org/10.1007/s10729-021-09563-3. [lead article]
‣ Liljenquist, Dan, Tinglong Dai, and Ge Bai. 2021. “A Nonprofit Public Utility Approach to Enhance Next-Generation Vaccine Manufacturing Capacity.” Population Health Management 24 (5): 546–547. https://doi.org/10.1089/pop.2020.0377.
‣ Dai, Tinglong, Muhammad H. Zaman, William Padula, and Patricia M. Davidson. 2021. “Supply Chain Failures Amid Covid-19 Signal a New Pillar for Global Health Preparedness.” Journal of Clinical Nursing 30(1–2): e1–e3.
‣ Dai, Tinglong, Ge Bai, and Gerard Anderson. 2020. “PPE Supply Chain Needs Data Transparency and Stress Testing.” Journal of General Internal Medicine 35(9): 2748-2749.
◦ Altmetric = 230 (as of July 2020); ranked No. 2 (the 98th percentile) of the 131 tracked articles of a similar age in Journal of General Internal Medicine and the 98th percentile of the 219,632 articles of a similar age in all journals
◦ Featured in the final report by the U.S. National Academies of Sciences, Engineering, and Medicine Committee on Security of America’s Medical Supply Chain
‣ Wuest, Thorsten, Andrew Kusiak, Tinglong Dai, and Sridhar R. Tayur. 2020. “Impact of COVID-19 on Manufacturing and Supply Networks — The Case for AI-Inspired Digital Transformation.” Working report. https://doi.org/10.2139/ssrn.3593540.
◦ A shortened version, entitled “Impact of COVID-19: The Case for AI-Inspired Digital Transformation,” was published in the June 2020 issue of OR/MS Today and featured on the cover.
‣ Dai, Tinglong, and Sridhar Tayur. 2017. “The Evolutionary Trends of POM Research in Manufacturing.” In Routledge Companion to Production and Operations Management. M. Starr and S. Gupta (Eds), pp. 647–662. London, U.K: Routledge. [Link to preprint]
‣ Dai, Tinglong, Soo-Haeng Cho, and Fuqiang Zhang. 2016. “Contracting for On-Time Delivery in the U.S. Influenza Vaccine Supply Chain.” Manufacturing & Service Operations Management 18 (3): 332–346. https://doi.org/10.1287/msom.2015.0574.
◦ Feature Article in the Summer 2016 issue of M&SOM
◦ Featured by Hub of Johns Hopkins University, Washington University in St. Louis Newsroom, and Pharmacy Times
AI in Supply Chains: Perspectives from Global Thought Leaders
Full Title: AI in Supply Chains: Perspectives from Global Thought Leaders
Co-editors: Maxime C. Cohen and Tinglong Dai
Publisher: Springer
DOI: 10.1007/978-3-032-07054-8
ISBN-10: 3032070538
Contributors
Handbook of Healthcare Analytics
Full Title: Handbook of Healthcare Analytics: Theoretical Minimum for Conducting 21st Century Research on Healthcare Operations
Editors: Tinglong Dai and Sridhar Tayur
Publisher: John Wiley & Sons, September 2018
ISBN: 978-1-119-30094-6
Endorsed by: Nitin Nohria, John P. Roberts, Alvin E. Roth, and Christopher S. Tang
Contributors
Buy/Read the Book
‣ David Simchi-Levi, Tinglong Dai, Ishai Menache, and Michelle Xiao Wu. 2025. Democratizing Optimization with Generative AI. Working paper.
‣ Chirantan Chatterjee and Tinglong Dai. 2025. How Can AI Speed Life-Saving Cures to Patients? BioProcess International 23(10): e1. October.
‣ Tinglong Dai, David Simchi-Levi. 2025. A New Hope? Insights from the 2025 Edition of INFORMS Journals’ Impact Factors. OR/MS Today. September 2.
‣ Tinglong Dai, Risa M. Wolf, and Haiyang Yang. 2025. “Unlearning in Medical AI: A New Frontier for Privacy, Regulation, and Trust.” Health Affairs Forefront. August 26.
‣ Holly Wiberg, , Tinglong Dai, Henry Lam, and Radhika Kulkarni. 2025. Synergizing Artificial Intelligence and Operations Research: Perspectives from INFORMS Fellows on the Next Frontier. INFORMS Journal on Data Science. July 8.
‣ Madeline Sagona, Tinglong Dai, Mario Macis, Michael Darden. 2025. Trust in AI-Assisted Health Systems and AI’s Trust in Humans. npj Health Systems. March 28.
‣ Stephen Gilbert, Tinglong Dai, Rebecca Mathias. 2025. Consternation as Congress Proposal for Autonomous Prescribing AI Coincides With the Haphazard Cuts at the FDA. npj Digital Medicine. March 18.
‣ Segev Wasserkrug, Vinod Cheriyan, Tinglong Dai, Juan R. Jaramillo, Sven Koenig, Ramayya Krishnan, Radhika Kulkarni, Henry Lam, Fred Oswald, Thiago Serra, Mark S. Squillante, Anjana Susarla, Pascal Van Hentenryck, Holly Wiberg. 2025. A Prominent Role for INFORMS in the Age of AI: Bringing Together AI and OR/MS for Better Organizational and Societal Decision-Making. OR/MS Today. March 3.
‣ Tinglong Dai, Christopher S. Tang. 2025. How Tariffs Can Hurt American Supply Chains. Baltimore Sun. February 25.
‣ Tinglong Dai. 2025. What to Watch in the Coming AI Policy Shake-Up. Deseret News. January 18.
‣ Tinglong Dai, Christopher S. Tang. 2024. De-risking Global Supply Chains: Looking Beyond Material Flows. Asia Policy 19 (4): 153–176. October 25. [Free PDF courtesy of the Hinrich Foundation]
‣ Tinglong Dai. 2024. Supply Chain Resilience in the Age of Climate Change. Pharma Manufacturing. September 25.
‣ Tinglong Dai. 2024. To Make Effective AI Policy You Must Trust Those Who’ve Been There. Federal News Network. June 11.
‣ Tinglong Dai, Michael Abramoff. 2024. Toward a Science of Scaling Medical Artificial Intelligence. Medical Economics. June 7.
‣ Tinglong Dai. 2024. History Says Tariffs Rarely Work, but Biden’s 100% Tariffs on Chinese EVs Could Defy the Trend. The Conversation. May 17.
‣ Kofi Arhin, Tinglong Dai. 2024. The Class of 2024 and the Art of Generative AI. Innovation & Tech Today. May 1.
‣ Yuna Nakayasu, Tinglong Dai. 2024. Taking Geographical Luck Out of Emergency Care With AI: Generative AI With Vision Will Be Essential to the Future of Emergency Medicine. EMS1. April 29.
‣ Michael Abramoff, Tinglong Dai, James Zou. 2024. Scaling Adoption of Medical Artificial Intelligence: Reimbursement from Value-Based Care and Fee-for-Service Perspectives. NEJM AI 1(5): AIpc2400083. April 12.
‣ Tinglong Dai. 2024. Despite Fears, Supply-Chain Crisis from Key Bridge Collapse Can Be Averted. Baltimore Banner. March 28.
‣ Tej D. Azad, Tinglong Dai. 2024. Do No Harm — The Imperative for Purposeful AI Regulation in Health Care. Medical Economics. March 21.
‣ Tinglong Dai. 2023. U.S. Needs to Shore Up Medical Device Manufacture or Risk Vulnerability in Times of Crisis. Baltimore Sun. December 26.
‣ Tinglong Dai, Christopher S. Tang, Hau Lee. 2023. LEGO’s ESG Dilemma: Why an Abandoned Plan to Use Recycled Plastic Bottles Is a Wake-Up Call for Supply Chain Sustainability. The Conversation. October 5.
‣ Tinglong Dai, Christopher S. Tang. 2023. China Derisking Is Inevitable. To Minimize the Pain, Supply Chains Need a Revolution. Barron’s. September 6.
‣ Tinglong Dai. 2023. The Role of Artificial Intelligence in Managing Postpandemic Supply-Chain Risks. BioProcess International 21(7–8), 56.
‣ Tinglong Dai, Christopher S. Tang. 2023. America’s Shaky Pharmaceutical Supply Chain Is a Prescription for Disaster. Barron’s. June 28.
‣ Tinglong Dai. 2023. Generative AI Is Not Entertainment — It Is Already a Threat to Our Way of Life. The Hill. June 10.
‣ Tinglong Dai. 2023. Is It Legal for Generative AI to Use Copyrighted Material without Permission? CQ Researcher. April 21.
‣ Tinglong Dai, Christopher S. Tang. 2022. China’s Sudden Shift on Zero-Covid Puts Supply Chains at Risk Again. Barron’s. December 14.
‣ Lauren Murphy, Tinglong Dai. 2022. Prioritizing Women Supply Chain Workers in ESG Efforts. Bloomberg Law. November 17.
‣ Tinglong Dai, Christopher S. Tang. 2022. Everybody Talks About Made in America. But It Isn’t That Simple. Wall Street Journal. October 23.
‣ Tinglong Dai, Ho-Yin Mak, Christopher S. Tang. 2022. Making EVs Without China’s Supply Chain Is Hard, but Not Impossible—3 Supply Chain Experts Outline a Strategy. The Conversation. August 31.
◦ Republished in MarketWatch
‣ Tinglong Dai, Ho-Yin Mak, Christopher S. Tang. 2022. With Monkeypox, the U.S. Is Repeating Its Covid Supply-Chain Mistakes. Barron’s. August 19.
‣ Tinglong Dai, Kara Morgan. 2022. In Fight Against Monkeypox, Government Isn’t Learning From Past Experience. Chicago Sun-Times. August 6.
‣ Tinglong Dai, Kara Morgan. 2022. The Food Safety System Is Failing. Industry Week. July 13.
‣ Tinglong Dai, Christopher S. Tang. 2022. The Baby Formula Crisis Shows the Urgent Need to Fix Supply Chain Resilience. Barron’s. June 2.
‣ Tinglong Dai. 2022. Supply Chain Transparency: A Growth Engine in the Wake of Crises. CEVA Insights. April 19.
‣ Tinglong Dai, Christopher S. Tang. 2022. It's the End of the Global Supply Chain as We Know It. Newsweek. April 19.
‣ Tinglong Dai. 2022. Russia’s War With Ukraine Could Permanently Reshape the Global Supply Chain. Fast Company. March 15
◦ Originally published in The Conversation on March 11, 2022, with the title of “Ukraine War and Anti-Russia Sanctions on Top of COVID-19 Mean Even Worse Trouble Lies Ahead for Global Supply Chains”
‣ Logesvar Balaguru, Chen Dun, Andrea Meyer, Sanuri Hennayake, Christi Walsh, Christopher Kung, Brittany Cary, Frank Migliarese, Tinglong Dai, Ge Bai, Kathleen Sutcliffe, Martin Makary. 2022. NIH Funding of COVID-19 Research in 2020: A Cross Sectional Study. BMJ Open 12(5), e059041. http://dx.doi.org/10.1136/bmjopen-2021-059041
◦ Featured by New York Times
‣ Tinglong Dai, Christopher S. Tang. 2022. Unifying ESG and Supply Chain Thinking: An Urgent Call to Action in the Post-Pandemic Era. AsiaGlobal Papers No. 5. January 6. Asia Global Institute, University of Hong Kong.
‣ Tinglong Dai, Christopher S. Tang. 2021. The Infrastructure Bill Is Here. Can America Still Do Megaprojects?. Barron’s. November 16.
‣ Tinglong Dai, Christopher S. Tang. 2021. ESG Investing Has a Blind Spot That Puts the $35 Trillion Industry’s Sustainability Promises in Doubt: Supply Chains. The Conversation. November 9.
‣ Tinglong Dai, Kate Dwyer. 2021. Q+A: Supply Chain Issues Spike Shoppers’ Demands. The Hub (Johns Hopkins University). November 1.
‣ Dan Liljenquist, Tinglong Dai, Ge Bai. 2021. A Nonprofit Public Utility Approach to Enhance Next-Generation Vaccine Manufacturing Capacity. Population Health Management 24(5), 546–547.
‣ Ravi Mittal, Surbhi Jain, Christopher G. Myers, Tinglong Dai, Amit Jain. 2021. A 100% COVID Vaccination Rate Is Possible – We Did It: The Raigarh Success Story Shows the Power of Behavioral and Motivational Strategies. MedPage Today. October 22.
‣ Sheldon H. Jacobson, Tinglong Dai. 2021. Lessons Learned From Hurricane Recovery Can Improve Supply Chains. The Hill. September 27.
‣ Tinglong Dai, Jeannette Song. 2021. Transforming COVID-19 Vaccines into Vaccination: Challenges and Opportunities for Management Scientists. Health Care Management Science (3): 455–59. https://doi.org/10.1007/s10729-021-09563-3. [lead article]
‣ Amit Jain, Tinglong Dai, Christopher G. Myers, Punya Jain, Shruti Aggarwal. 2021. Prioritising Surgical Cases Deferred by the COVID-19 Pandemic: An Ethics-Inspired Algorithmic Framework for Health Leaders. BMJ Leader 5(2), 124–126.
‣ Tinglong Dai. 2021. Why Johnson & Johnson Throwing Out 15 Million COVID-19 Vaccine Doses Shouldn’t Scare You. The Conversation, April 1.
‣ Tinglong Dai, Christopher S. Tang, Ho-Yin Mak. 2021. Opinion: The Backlash Against Johnson & Johnson’s COVID-19 Vaccine Is Real and Risky — Here’s Exactly How To Make the Rollout a Success. MarketWatch. March 10.
◦ Read more than 700,000 times across The Conversation and MarketWatch, among other outlets
◦ Originally published in The Conversation on March 5, 2021, with the title of “Backlash Against Johnson & Johnson’s COVID-19 Vaccine Is Real and Risky – Here’s How To Make Its Rollout a Success”
‣ Tinglong Dai, Ho-Yin Mak, Christopher S. Tang. 2021. The Great Promise of a One-Dose Vaccine. Barron’s. February 26.
‣ Tinglong Dai. 2021. How To Fix the Mess of COVID-19 Vaccine Appointment Scheduling. Fast Company. February 23.
◦ Originally published in The Conversation on February 22, 2021, with the title of “How To Really Fix COVID-19 Vaccine Appointment Scheduling”
◦ Republished in The Daily Beast, MarketWatch, Nextgov, and Yahoo! News
‣ Tinglong Dai. 2021. The US Government’s $44 Million Vaccine Rollout Website Was a Predictable Mess – Here’s How To Fix the Broken Process Behind It. The Conversation. February 4.
‣ Tinglong Dai. 2021. The Simple Reason West Virginia Leads the Nation in Vaccinating Nursing Home Residents. The Associated Press. January 29.
◦ Originally published in The Conversation on January 14, 2021
◦ Republished in Fast Company, Quartz, and U.S. News & World Report
‣ Tinglong Dai, Prashant Yadav. 2021. Why Holding Second Doses of COVID-19 Vaccines in Reserve Is the Wrong Strategy. USA Today. January 12.
◦ Published in the national print edition (January 13, page 7A) with the title of “Release Second Doses To Speed Vaccinations”
‣ Saralyn Cruickshank, Tinglong Dai. 2021. Q+A: Making Sense of the Lagging U.S. COVID-19 Vaccination Effort. The Hub (Johns Hopkins University). January 8.
‣ Tinglong Dai, Muhammad H. Zaman, William Padula, Patricia M. Davidson. 2021. Supply Chain Failures Amid Covid-19 Signal a New Pillar for Global Health Preparedness. Journal of Clinical Nursing, 30(1–2), e1-e3.
‣ Tinglong Dai, Shubhranshu Singh. 2020. COVID-19 Diagnostic Testing and Viral Load Reporting. VoxEU.org. December 23.
‣ Tinglong Dai, Christopher S. Tang. 2020. How to Distribute the COVID-19 Vaccine: Lessons From Amazon and Walmart. Fast Company. December 16.
◦ Originally published in The Conversation on December 15, 2020, with the title of “What Vaccine Distribution Planners Can Learn From Amazon and Walmart”
◦ Republished in National Interest, Quartz, Salon, and Scroll.in
◦ Translated to Spanish and published in El Financiero and The Logistics World
‣ Tinglong Dai, Patrick Ercolano. 2020. Q+A: The Business of Delivering a Pandemic Vaccine. The Hub (Johns Hopkins University). December 4.
‣ Tinglong Dai, Guihua Wang, Ronghuo Zheng. 2020. How the Airline Industry Recovers From COVID-19 Could Determine Who Gets Organ Transplants. The Conversation. September 28.
◦ Based on the paper entitled “Does Transportation Mean Transplantation? Impact of New Airline Routes on Sharing of Cadaveric Kidneys”
◦ Republished by Associated Press, Austin’ NPR Station—KUT, Houston Chronicle, Public Radio International, National Interest, Simple Flying, and Yahoo! News
‣ Tinglong Dai, Christopher S. Tang. 2020. Safety First for Online Markets, or Customers May Shop Elsewhere. Barron’s. August 25. (Republished in MarketWatch.)
‣ Amit Jain, Tinglong Dai, Kristin Bibee, Christopher G. Myers. 2020. Covid-19 Created an Elective Surgery Backlog. How Can Hospitals Get Back on Track? Harvard Business Review. August 10 (PDF).
‣ Tinglong Dai, Christopher S. Tang. 2020. Amazon Has a Trust Problem. Barron’s. August 7. (Republished in MarketWatch.)
‣ Ge Bai, Tinglong Dai, Shivaram Rajgopal. 2020. The PPE Supply Chain Is a Black Box—That Needs to Change. Fortune. July 25.
‣ Tinglong Dai, Christopher S. Tang. 2020. How to Build a Coronavirus Vaccine Supply Chain. Bloomberg Law. July 21.
‣ Tinglong Dai, Christopher S. Tang. 2020. Influenza Vaccine Supply Chain Lessons for Coronavirus. Bloomberg Law. July 21.
‣ Tinglong Dai, Christopher S. Tang. 2020. Too Fast, Too Furious: Is U.S. Vaccine Development Headed in the Wrong Direction? Barron’s. July 16. (Republished in MarketWatch.)
‣ Tinglong Dai, Ge Bai, Gerard Anderson. 2020. PPE Supply Chain Needs Data Transparency and Stress Testing. Journal of General Internal Medicine 35(9), 2748–2749.
◦ Altmetric = 230 (as of July 2020); ranked No. 2 (the 98th percentile) of the 131 tracked articles of a similar age in Journal of General Internal Medicine and the 98th percentile of the 219,632 articles of a similar age in all journals
‣ Tinglong Dai. 2020. Where Does Your PPE Come From? A Lack of Transparency Is Hurting Americans. Fast Company. July 15.
◦ Originally published in The Conversation on July 13, 2020, under the title of “What US Medical Supply Chain Can Learn From the Fashion Industry”; also republished in Yahoo! News, Scroll.in, Mic, and Houston Chronicle
‣ Tinglong Dai, Christopher S. Tang. 2020. The U.S. Medical Supply Chain Isn’t Ready for a Second Wave. Barron’s. June 24. Featured Article. (Republished in MarketWatch.)
‣ Thorsten Wuest, Andrew Kusiak, Tinglong Dai, Sridhar Tayur. 2020. Impact of COVID-19: The Case for AI-Inspired Digital Transformation. OR/MS Today. 47 (3) 34–39.
‣ Tinglong Dai, Christopher S. Tang. 2020. Needed: A PPE Industrial Commons. EE Times. May 27.
‣ Tinglong Dai, Ashley Kilgore, Sridhar Tayur. 2020. From Products to People: The Growing Impact of Supply Chain Interruptions during the Coronavirus Pandemic. Resoundingly Human Podcast (INFORMS). March 18.
‣ Goker Aydin, Tinglong Dai, Tim Parsons. 2020. Q+A: How Coronavirus Will Affect the Global Supply Chain. The Hub (Johns Hopkins University). March 6.
Honors & Awards
for the project “Personalized Radiation Therapy Treatment Planning” (role: co-PI)
for the paper “Jumping the Line, Charitably: Analysis and Remedy of Donor-Priority Rule”
for the project “Clinical Ambiguity and Conflicts of Interests in Interventional Cardiology Decision-Making” (role: lead PI)
for the paper entitled “Imaging Room and Beyond: The Underlying Economics behind Physicians’ Test-Ordering Behavior in Outpatient Services.”
for the paper entitled “Contracting for On-Time Delivery in the U.S. Influenza Vaccine Supply Chain.”
for the paper entitled “Clinical Ambiguity and Conflicts of Interests in Interventional Cardiology Decision-Making.”
for the paper entitled “Contracting for On-Time Delivery in the U.S. Influenza Vaccine Supply Chain.”
for the dissertation entitled “Incentives in U.S. Healthcare Operations” (Summary).
for the teaching case “Patient Experience Improvement at UPMC Eye Center.”